Xolair inhaler?

Xolair is not an inhaler. Xolair is the brand name for omalizumab, a monoclonal antibody that is given as a subcutaneous injection in a clinic or doctor’s office.

Key points:
- How it’s given: subcutaneous injection (not inhaled). Dosing is usually every 2 to 4 weeks, depending on body weight and baseline IgE level, and the specific condition being treated.
- What it’s used for: usually severe persistent allergic asthma with evidence of allergic sensitization, and chronic spontaneous urticaria (hives) that hasn’t responded to usual treatments.
- Not a rescue medicine: it doesn’t treat acute asthma symptoms or sudden allergic reactions.
- Safety: injections are given under medical supervision because of a small risk of anaphylaxis; you’ll be monitored after the first dose and sometimes after subsequent doses.
- Common side effects: pain or redness at the injection site, headaches, fatigue, and upper respiratory symptoms. Serious allergic reactions are rare but important to recognize.

If you’re asking because you’re considering Xolair or are wondering about alternatives (like other biologics or inhaled therapies), I can share more details. Do you want information on eligibility, dosing ranges, or potential alternatives?